-
Rotigotine Beyond Motor Symptoms: A Translational Roadmap
2026-09-02
Rotigotine is more than a dopaminergic symptomatic tool. By connecting receptor pharmacology, oxidative stress biology, delivery strategy, and lower urinary tract phenotyping, this article presents a translational framework for Parkinson’s disease research and more informative preclinical decision-making.
-
LC-MS/MS Reveals Carbapenemase Resistance
2026-09-02
A 2025 study used antibiotic-free LC-MS/MS metabolomics, multivariate analysis, and supervised machine learning to distinguish carbapenemase-producing Enterobacterales from non-producing isolates. Its metabolite signatures provide mechanistic clues about resistance biology and a possible route toward faster diagnostics than conventional culture-based workflows.
-
BMAL1 Phase Separation and Circadian Transcription
2026-09-01
Gao et al. identify BMAL1 as a phase-separating transcription factor whose phosphorylation-sensitive N-terminal intrinsically disordered region supports dynamic nuclear condensates. These condensates recruit transcriptional machinery and are required for rhythmic gene expression and locomotor behavior, providing a mechanistic explanation for why BMAL1 DNA binding alone does not fully predict transcriptional output.
-
Rotavirus Infection and Nrf2 Redox Defense
2026-09-01
The reference study shows that rotavirus infection produces a transient early Nrf2 response followed by progressive depletion of Nrf2, nuclear Nrf2 activity, and antioxidant gene expression. Its pharmacological and ubiquitination experiments indicate that late Nrf2 loss is not simply a consequence of oxidative stress or canonical Keap1 turnover, but is associated with proteasome-dependent, K48-linked ubiquitination.
-
EZ Cap EGFP mRNA 5-moUTP: Workflow Guide
2026-08-31
Build more reproducible reporter, delivery, and translation experiments with a Cap1-capped, 5-moUTP-modified EGFP transcript. This practical guide connects cell-based optimization with nanoparticle formulation choices and in vivo imaging controls.
-
Meropenem trihydrate in resistance research
2026-08-31
Meropenem trihydrate supports more than routine susceptibility testing: it can connect antibacterial activity, resistance phenotypes, and metabolomic signatures in one experimental strategy. This guide presents practical workflows for Enterobacterales studies, assay optimization, and carefully controlled translational models.
-
Puerarin, Nitric Oxide, and Dental Follicle Osteogenesis
2026-08-30
The 2021 reference study provides evidence that puerarin enhances osteogenic differentiation in rat dental follicle cells through nitric oxide signaling. Its use of L-NMMA as a pathway-level perturbation connects nitric oxide production with osteogenic markers, offering a useful framework for periodontal regeneration research while leaving isoform-specific and in vivo questions unresolved.
-
How to Measure Anticancer Drug Response In Vitro
2026-08-29
Hannah R. Schwartz’s dissertation shows that relative viability and fractional viability capture different components of an anticancer response: growth inhibition and cell killing. Its central practical contribution is a time-aware framework for interpreting drug effects, helping researchers avoid treating proliferation arrest and apoptosis as interchangeable outcomes.
-
S-Adenosylhomocysteine in Neural Assay Design
2026-08-28
S-Adenosylhomocysteine (SAH) is more than a methylation-cycle metabolite: it can serve as a controlled perturbation for testing whether metabolic methylation potential influences radiation-associated neural phenotypes. This article separates established evidence from proposed assay applications and translates pathway findings into rigorous experimental design.
-
Metabolomics Reveals Carbapenemase Resistance
2026-08-28
The 2025 reference study used LC-MS/MS profiling and supervised machine learning to distinguish carbapenemase-producing Enterobacterales from non-producing isolates under antibiotic-free conditions. Its metabolite signatures provide mechanistic clues about resistance biology and a possible route toward faster diagnostic testing, while still requiring validation in larger, independent isolate collections.
-
Rotigotine: From Receptor Agonism to Translation
2026-08-27
Rotigotine is more than a dopamine D2/D3 receptor agonist: its multi-receptor pharmacology, route-dependent effects, and potential autonomic applications make it a valuable translational tool for Parkinson’s disease research.
-
EPI-001: Androgen Receptor N-Terminal Domain Inhibitor
2026-08-27
EPI-001 enables pathway-focused studies of full-length androgen receptor and AR splice variants that can evade ligand-binding-domain inhibition. This practical guide covers dose-response design, prostate cancer and TNBC workflows, metastasis readouts, and troubleshooting for reliable androgen receptor pathway experiments.
-
AM251 as a Mechanistic Probe of CB1 Signaling
2026-08-26
AM251 is a potent CB1 receptor antagonist for dissecting endocannabinoid signaling across neural, metabolic, and cell-state assays. This article explains how to use it as a causal pharmacology tool, particularly when interpreting cannabidiol effects in pain and affective circuitry.
-
AMPK Suppresses Autophagy During Energy Stress
2026-08-26
The reference study challenges the canonical view that AMPK universally promotes autophagy during nutrient deprivation. It shows that AMPK restrains ULK1-dependent autophagy initiation during severe energy stress while preserving the autophagy machinery for recovery after stress subsides.
-
Rosiglitazone and the Next Frontier of Fat Browning
2026-08-25
Rosiglitazone is more than a classic PPARγ tool: it can serve as a pharmacological benchmark for separating adipogenesis, insulin sensitivity, and thermogenic remodeling. When paired with the SETD7–Adcy7–Sirt1–CREB1 framework, Brl-49653 helps translational researchers design sharper experiments around white adipose browning and metabolic resilience.